As EAE and MS also involved glial cells, it could further explain the role of LXR activation in the development of these diseases [72,73,74] Moreover, LXRα has been shown to modulate the BBB permeability and to affect EAE severity. This evidence concerns the gene NR1H3 and myeloid sarcoma.